Psychopharmacology

, Volume 231, Issue 4, pp 685–693

A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression

  • Chen Zhang
  • Zezhi Li
  • Zhiguo Wu
  • Jun Chen
  • Zuowei Wang
  • Daihui Peng
  • Wu Hong
  • Chengmei Yuan
  • Zhen Wang
  • Shunying Yu
  • Yifeng Xu
  • Lin Xu
  • Zeping Xiao
  • Yiru Fang
Original Investigation

DOI: 10.1007/s00213-013-3297-0

Cite this article as:
Zhang, C., Li, Z., Wu, Z. et al. Psychopharmacology (2014) 231: 685. doi:10.1007/s00213-013-3297-0

Abstract

Rationale

In clinical practice, ketamine, an antagonist of the N-methyl-d-aspartate receptor (NMDAR), is used to alleviate depressive symptoms in patients with major depressive disorder (MDD), especially in those with treatment-resistant depression (TRD). Accordingly, the human gene coding for the 2B subunit of the NMDAR (GRIN2B) is considered a promising candidate gene for MDD susceptibility.

Objectives

The primary aim of this study is to examine whether potentially functional polymorphisms of GRIN2B confer risk for MDD, and second to investigate whether GRIN2B acts as a genetic predictor for TRD in MDD patients.

Methods

We enrolled 178 TRD and 612 non-TRD patients as well as 779 healthy controls.

Results

Four potentially functional polymorphisms (rs1805502, rs890, rs1806201, and rs7301328) within GRIN2B were genotyped in all participants. The haplotype analysis found significant differences in the distribution of the G–T haplotype between the TRD and control groups (corrected P = 0.007), and the frequency of the G–T haplotype in TRD group was significantly higher than that in the controls (TRD/control ratio 0.31:0.21). Statistically significant differences in allele and genotype frequencies were detected between TRD and non-TRD groups for the rs1805502 polymorphism within GRIN2B. There was a significant allelic association between rs1805502 and TRD with an excess of the G allele in the TRD group, compared to non-TRD group (OR = 1.55, 95 % CI = 1.18–2.05, corrected P = 0.008).

Conclusions

These initial findings strengthen the hypothesis that GRIN2B not only confers susceptibility to TRD, but also plays a genetic predictor for TRD in MDD patients.

Keywords

GRIN2BMajor depressive disorderTreatment-resistant depressionGenetic predictor

Supplementary material

213_2013_3297_MOESM1_ESM.doc (338 kb)
ESM 1(DOC 337 kb)

Copyright information

© Springer-Verlag Berlin Heidelberg 2013

Authors and Affiliations

  • Chen Zhang
    • 1
    • 2
  • Zezhi Li
    • 3
  • Zhiguo Wu
    • 1
  • Jun Chen
    • 1
  • Zuowei Wang
    • 1
  • Daihui Peng
    • 1
  • Wu Hong
    • 1
  • Chengmei Yuan
    • 1
  • Zhen Wang
    • 5
  • Shunying Yu
    • 6
  • Yifeng Xu
    • 1
  • Lin Xu
    • 2
  • Zeping Xiao
    • 5
  • Yiru Fang
    • 1
  1. 1.Division of Mood Disorders, Shanghai Mental Health CenterShanghai Jiao Tong University School of MedicineShanghaiChina
  2. 2.Key Laboratory of Animal Models and Human Disease Mechanisms of the Chinese Academy of Sciences and Yunnan ProvinceKunming Institute of ZoologyKunmingChina
  3. 3.Department of Neurology, Shanghai Changhai HospitalSecondary Military Medical UniversityShanghaiChina
  4. 4.Department of PsychiatryHongkou District Mental Health Center of ShanghaiShanghaiChina
  5. 5.Department of Clinical Psychology, Shanghai Mental Health CenterShanghai Jiao Tong University School of MedicineShanghaiChina
  6. 6.Department of Genetics, Shanghai Mental Health CenterShanghai Jiao Tong University School of MedicineShanghaiChina